Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-08-23 04:02:03 UTC |
---|
Updated at | 2024-09-03 04:16:51 UTC |
---|
NP-MRD ID | NP0331773 |
---|
Natural Product DOI | https://doi.org/10.57994/0833 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (6 S,7E)− 6-hydroxy-4,7-megastigmadien-3,9-dione (S(+)-dehydrovomifoliol) |
---|
Description | (+)-Dehydrovomifoliol belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive isoprene units. Thus, (+)-dehydrovomifoliol is considered to be an isoprenoid. (6 S,7E)− 6-hydroxy-4,7-megastigmadien-3,9-dione (S(+)-dehydrovomifoliol) was first documented in 2019 (PMID: 31542954). Based on a literature review a small amount of articles have been published on (+)-Dehydrovomifoliol (PMID: 33668728) (PMID: 33383824) (PMID: 32627491) (PMID: 31359654). |
---|
Structure | [H]O[C@]1(\C([H])=C(/[H])C(=O)C([H])([H])[H])C(=C([H])C(=O)C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] InChI=1S/C13H18O3/c1-9-7-11(15)8-12(3,4)13(9,16)6-5-10(2)14/h5-7,16H,8H2,1-4H3/b6-5+/t13-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(4S)-4-Hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxobut-1-enyl]cyclohex-2-en-1-one | ChEBI | (6R)-6-Hydroxy-3-oxo-alpha-ionone | ChEBI | (6S)-6-Hydroxy-3-oxo-alpha-ionone | ChEBI | Dehydrovomifoliol | ChEBI | (6R)-6-Hydroxy-3-oxo-a-ionone | Generator | (6R)-6-Hydroxy-3-oxo-α-ionone | Generator | (6S)-6-Hydroxy-3-oxo-a-ionone | Generator | (6S)-6-Hydroxy-3-oxo-α-ionone | Generator |
|
---|
Chemical Formula | C13H18O3 |
---|
Average Mass | 222.2840 Da |
---|
Monoisotopic Mass | 222.12559 Da |
---|
IUPAC Name | (4S)-4-hydroxy-3,5,5-trimethyl-4-[(1E)-3-oxobut-1-en-1-yl]cyclohex-2-en-1-one |
---|
Traditional Name | dehydrovomifoliol |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]O[C@]1(\C([H])=C(/[H])C(=O)C([H])([H])[H])C(=C([H])C(=O)C([H])([H])C1(C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] |
---|
InChI Identifier | InChI=1S/C13H18O3/c1-9-7-11(15)8-12(3,4)13(9,16)6-5-10(2)14/h5-7,16H,8H2,1-4H3/b6-5+/t13-/m1/s1 |
---|
InChI Key | JJRYPZMXNLLZFH-URWSZGRFSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | guangxzh@sina.com | Not Available | Not Available | 2024-05-09 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | guangxzh@sina.com | Not Available | Not Available | 2024-05-09 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CD3OD, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 400, CDCl3, simulated) | Not Available | Not Available | Not Available | 2024-05-09 | View Spectrum |
| Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
orellana | | |
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as sesquiterpenoids. These are terpenes with three consecutive isoprene units. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Sesquiterpenoids |
---|
Direct Parent | Sesquiterpenoids |
---|
Alternative Parents | |
---|
Substituents | - Sesquiterpenoid
- Megastigmane sesquiterpenoid
- Cyclofarsesane sesquiterpenoid
- Ionone derivative
- Cyclohexenone
- Acryloyl-group
- Enone
- Alpha,beta-unsaturated ketone
- Tertiary alcohol
- Ketone
- Cyclic ketone
- Organic oxide
- Organic oxygen compound
- Organooxygen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Yuzikhin OS, Gogoleva NE, Shaposhnikov AI, Konnova TA, Osipova EV, Syrova DS, Ermakova EA, Shevchenko VP, Nagaev IY, Shevchenko KV, Myasoedov NF, Safronova VI, Shavarda AL, Nizhnikov AA, Belimov AA, Gogolev YV: Rhizosphere Bacterium Rhodococcus sp. P1Y Metabolizes Abscisic Acid to Form Dehydrovomifoliol. Biomolecules. 2021 Feb 25;11(3). pii: biom11030345. doi: 10.3390/biom11030345. [PubMed:33668728 ]
- Malarz J, Michalska K, Stojakowska A: Stem Lettuce and Its Metabolites: Does the Variety Make Any Difference? Foods. 2020 Dec 29;10(1). pii: foods10010059. doi: 10.3390/foods10010059. [PubMed:33383824 ]
- Feng ZY, Ma YX, Wang H, Chen M: [Studies on chemical constituents of stems of Herpetospermum pedunculosum]. Zhongguo Zhong Yao Za Zhi. 2020 Jun;45(11):2571-2577. doi: 10.19540/j.cnki.cjcmm.20200227.201. [PubMed:32627491 ]
- Bendjedou H, Barboni L, Maggi F, Bennaceur M, Benamar H: Alkaloids and sesquiterpenes from roots and leaves of Lycium europaeum L. (Solanaceae) with antioxidant and anti-acetylcholinesterase activities. Nat Prod Res. 2019 Sep 23:1-5. doi: 10.1080/14786419.2019.1666386. [PubMed:31542954 ]
- Sun DX, Guo XF, A LT, Ma XL, Wei HY, Ma GX, Shi LL, Zhang J: [Chemical constituents from green walnut husks and their antitumor activity in vitro]. Zhongguo Zhong Yao Za Zhi. 2019 Jun;44(11):2278-2282. doi: 10.19540/j.cnki.cjcmm.20190321.201. [PubMed:31359654 ]
|
---|